BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information Letter on Palexia® 20 mg/ml oral solution (tapentadol): administration to children and adolescents in hospitals

Active substance: tapentadol

The company Grünenthal is circulating information on a new dosing pipette for weight-based dosing in children with a body weight of more than 16 kg.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 1MB, File does not meet accessibility standards

Use of cookies

Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)

OK